E-LIB Suche - Ergebnisse für: Pei-Chang Lee

1

THU-464 aMAP score predicts progression-free survival in pa..:

Vithayathil, Mathew ; D'Alessio, Antonio ; Fulgenzi, Claudia...
Journal of Hepatology. 80 (2024) - p. S443 , 2024

Link: https://doi.org/10.1016/..

2

THU-479 The features of gut microbiota and metabolites in n..:

Lee, Pei-Chang ; Hung, Ya-Wen ; Wu, Chi-Jung...
Journal of Hepatology. 80 (2024) - p. S449 , 2024

Link: https://doi.org/10.1016/..

3

A meta-analysis and real-world cohort study on the sex-rela..:

Balcar, Lorenz ; Scheiner, Bernhard ; Fulgenzi, Claudia Angela Maria...
JHEP Reports. 6 (2024) 2 - p. 100982 , 2024

Link: https://doi.org/10.1016/..

4

OS-112-YI Outcome and management of patients with hepatocel..:

Scheiner, Bernhard ; Kang, Beodeul ; Balcar, Lorenz...
Journal of Hepatology. 80 (2024) - p. S69 , 2024

Link: https://doi.org/10.1016/..

5

Characteristics and outcomes of immunotherapy-related liver..:

Celsa, C. ; Cabibbo, G. ; Fulgenzi, C. AM...
Digestive and Liver Disease. 56 (2024) - p. S76-S78 , 2024

Link: https://doi.org/10.1016/..

6

Sa1583 ENDOSCOPIC VARICEAL LIGATION VERSUS PROPRANOLOL FOR ..:

Yang, Tsung-Chieh ; Chen, Wenchi ; Hou, Ming-Chih...
Gastroenterology. 166 (2024) 5 - p. S-1583 , 2024

Link: https://doi.org/10.1016/..

7

Characteristics and outcomes of immunotherapy-related liver..:

Celsa, Ciro ; Cabibbo, Giuseppe ; Fulgenzi, Claudia A.M....
Journal of Hepatology. 80 (2024) 3 - p. 431-442 , 2024

Link: https://doi.org/10.1016/..

8

Conventional and machine learning-based risk scores for pat..:

Ho, Chun-Ting ; Tan, Elise Chia-Hui ; Lee, Pei-Chang...
Clinical and Molecular Hepatology. 30 (2024) 3 - p. 406-420 , 2024

Link: https://doi.org/10.3350/..

9

OS-078-YI Hepatic decompensation as an aetiology-dependent ..:

Celsa, Ciro ; Cabibbo, Giuseppe ; Fulgenzi, Claudia...
Journal of Hepatology. 80 (2024) - p. S51-S52 , 2024

Link: https://doi.org/10.1016/..

10

Prognostic Nutritional Index as a Prognostic Factor for Ver..:

Ho, Chun-Ting ; Chia-Hui Tan, Elise ; Lee, Pei-Chang...
Clinical and Translational Gastroenterology. 15 (2024) 4 - p. e00678 , 2024

Link: https://doi.org/10.14309..

11

Outcomes of Post-Immunotherapy Durable Responders of Advanc..:

Liu, Tsung-Hao ; Chen, San-Chi ; Rau, Kun-Ming...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

12

Feasibility estimation of injected hydrodissection before d..:

Wu, Yuan-Hung ; Shen, Shu-Huei ; Wang, Yen-Po...
Journal of the Chinese Medical Association. 87 (2024) 5 - p. 511-515 , 2024

Link: https://doi.org/10.1097/..

13

Efficacy and safety of atezolizumab/bevacizumab in patients..:

Joerg, Vincent ; Scheiner, Bernhard ; D´Alessio, Antonio...
Hepatology Communications. 7 (2023) 11 - p. , 2023

Link: https://doi.org/10.1097/..

14

Impact of body mass index in patients receiving atezolizuma..:

Vithayathil, Mathew ; D'Alessio, Antonio ; Fulgenzi, Claudia Angela Maria...
Hepatology International. 17 (2023) 4 - p. 904-914 , 2023

Link: https://doi.org/10.1007/..

15

A novel AFP-M2BPGi score has better performance than CRAFIT..:

Lee, Pei-Chang ; Wu, Chijung ; Huang, Kuo-Wei...
Journal of Hepatology. 78 (2023) - p. S496-S497 , 2023

Link: https://doi.org/10.1016/..